These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31916190)

  • 1. Patient-Specific Cells for Modeling and Decoding Amyotrophic Lateral Sclerosis: Advances and Challenges.
    Zhao A; Pan Y; Cai S
    Stem Cell Rev Rep; 2020 Jun; 16(3):482-502. PubMed ID: 31916190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
    Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
    Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
    Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
    Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ALS disease modeling and drug screening using patient-specific iPS cells].
    Egawa N; Inoue H
    Rinsho Shinkeigaku; 2013; 53(11):1020-2. PubMed ID: 24291866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique.
    Toli D; Buttigieg D; Blanchard S; Lemonnier T; Lamotte d'Incamps B; Bellouze S; Baillat G; Bohl D; Haase G
    Neurobiol Dis; 2015 Oct; 82():269-280. PubMed ID: 26107889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
    Sun X; Song J; Huang H; Chen H; Qian K
    Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).
    Martin LJ; Price AC; Kaiser A; Shaikh AY; Liu Z
    Int J Mol Med; 2000 Jan; 5(1):3-13. PubMed ID: 10601567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement?
    Silani V; Calzarossa C; Cova L; Ticozzi N
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):314-24. PubMed ID: 20406179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis.
    Ziff OJ; Patani R
    Aging Cell; 2019 Feb; 18(1):e12862. PubMed ID: 30565851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
    Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
    Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS, a cellular whodunit on motor neuron degeneration.
    Karagiannis P; Inoue H
    Mol Cell Neurosci; 2020 Sep; 107():103524. PubMed ID: 32629110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis.
    Nikel LM; Talbot K; Vahsen BF
    Bioessays; 2024 Jul; 46(7):e2400054. PubMed ID: 38713169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant UBQLN2
    Chen T; Huang B; Shi X; Gao L; Huang C
    Acta Neuropathol Commun; 2018 Nov; 6(1):122. PubMed ID: 30409191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
    Bohl D; Pochet R; Mitrecic D; Nicaise C
    Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Human Pluripotent Stem Cells in Amyotrophic Lateral Sclerosis: From Biological Mechanism to Practical Implications.
    Ceccarelli L; Verriello L; Pauletto G; Valente M; Spadea L; Salati C; Zeppieri M; Ius T
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):114. PubMed ID: 38538275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease.
    Jaiswal MK
    Neural Regen Res; 2017 May; 12(5):723-736. PubMed ID: 28616022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling ALS with motor neurons derived from human induced pluripotent stem cells.
    Sances S; Bruijn LI; Chandran S; Eggan K; Ho R; Klim JR; Livesey MR; Lowry E; Macklis JD; Rushton D; Sadegh C; Sareen D; Wichterle H; Zhang SC; Svendsen CN
    Nat Neurosci; 2016 Apr; 19(4):542-53. PubMed ID: 27021939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
    Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
    Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.